Evidence Based Medicine presented by InpharmD™

InpharmD™
  • 4.5 (8)
  • MEDICINE

We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.

  1. Ketamine for Sickle Cell Disease

    08/28/2024

    Ketamine for Sickle Cell Disease

    InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.

    13 min
  2. Tirzepatide for Sleep Apnea

    07/26/2024

    Tirzepatide for Sleep Apnea

    InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the SURMOUNT-OSA clinical trials.

    11 min
  3. Excoriation Disorder

    05/28/2024

    Excoriation Disorder

    InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.

    11 min
  4. Phenytoin for Tacrolimus Toxicity

    04/25/2024

    Phenytoin for Tacrolimus Toxicity

    InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.

    14 min
  5. Atypical Antipsychotics and QT–prolongation

    02/27/2024

    Atypical Antipsychotics and QT–prolongation

    InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that's been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.

    11 min
  6. Apixaban in Peripheral Artery Disease

    11/30/2023

    Apixaban in Peripheral Artery Disease

    Join InpharmD as we discuss the role of apixaban in peripheral artery disease.

    11 min
  7. Safety and Efficacy of RSV Vaccines

    09/27/2023

    Safety and Efficacy of RSV Vaccines

    Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.

    10 min
  8. Safety and Efficacy of Rezafungin

    07/20/2023

    Safety and Efficacy of Rezafungin

    Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!

    10 min
See All (78)

Ratings & Reviews

4.5
out of 5
8 Ratings

About

We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.

Information